Generics Bulletin is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vanda Lodges ANDA Trade Secret Case Against US Government

Originator Makes Claims Over Its Fanapt And Hetlioz Brands

Executive Summary

US originator Vanda Pharmaceutical namechecked several generics manufacturers, including Teva, as part of its trade secrets and confidential information lawsuit against the US government.

You may also be interested in...



What’s Next? Five Things To Look Out For In August

Generics Bulletin previews the most notable and anticipated events for August 2023.

Don’t Push Mayo To The Side, Hikma Urges Top US Court

The US Supreme Court should insist that the Court of Appeals for the Federal Circuit respect the landmark Mayo ruling that renders pharmaceutical method-of-treatment patents liable to the same eligibility criteria as other patents, Hikma argues in a petition just filed.

Takeda Pens Mid-Trial Settlement To Dismiss US Colcrys Antitrust Suit

Japanese originator Takeda has agreed to settle two-year-old anticompetitive claims lodged by wholesalers in the US that it conspired with several generics manufacturers to maintain supracompetitive pricing for its Colcrys branded treatment for gout.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

GB152696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel